A year ago, AstraZeneca (AZ) launched a ‘Million Hour Challenge’ to encourage its employees to find novel ways to cut unnecessary and time-consuming tasks in favour of truly productive work tha
Lonza has boosted its ability to cater for customers in the fast-emerging antibody-drug conjugate category with a deal to buy Dutch company Synaffix and its platform techn